LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial
| Autor: | Bourhis, J., Sire, C., Tao, Y., Martin, L., Alfonsi, M., Prevost, J.B., Rives, M., Lafond, C., Tourani, J.M., Biau, J., Geoffrois, L., Coutte, A., Liem, X., Vauleon, E., Drouet, F., Pechery, A., Guigay, J., Wanneveich, M., Aupérin, A., Sun, X. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S1168-S1168 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|